Clinical Pharmacology & Biopharmaceutics
Open Access

Corry D Bondi

Division of Clinical, Social and Administrative Sciences, School of Pharmacy, Duquesne University, Pittsburgh, PA, USA

Biography

Corry D Bondi received Ph.D in Pharmacology and Toxicology from University of Arizona, B.S in Biochemistry, from University of Illinois.he is currently working as Associate professor of  Clinical, Social and Administrative Sciences at School of Pharmacy, Duquesne University, Pittsburgh, PA, USA.he is the member of  Society for Neuroscience,  American Association of Colleges of Pharmacy,American Society for Pharmacology and Experimental Therapeutics , University of Pittsburgh Cancer.Institute Cancer Stem Cell Biology Program , Center for Environmental Oncology

Publications

An Early Development Budget Impact Model for the Use of Melatonin in the Treatment and Prevention of Osteoporosi

In the U.S., there are approximately 9 million adults with osteoporosis (OP) and an additional 43 million at-risk. By 2030, this number is expected to increase to 68 million adults. The economic impact is estimated to be $23 billion by 2025. Current drug therapies either decrease bone resorption (e.g., bisphosphonates) or stimulate bone formation (... Read More»

Corry D Bondi, Rahul Khairnar, Khalid M. Kamal and Paula Witt-Enderby

Research Article: Clin Pharmacol Biopharm 2015, 4:132

DOI: 10.4172/2167-065X.1000132

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF